Lifeboat Foundation

With electrodes up the nose, they made people smell things that weren’t there.

A team of Harvard physicists recently published research showing how future telescopes will rely on quantum entanglement to see across the universe.

A new type of _Archaeopteryx_ fossil helps build the case for this creature being called ‘the first bird’.

Colour blindness, otherwise known as colour vision deficiency, affects around 8% of men.

The future of flight

The next all-electric vehicle is the airplane.

by Sasha Lekach

Astrophysicist digs deep into quark stars in the latest episode of ‘Ask a Spaceman.’

NASA has released an image of the Earth captured by the Parker Solar Probe on its historic journey to the Sun.

The picture was captured on Sept. 25 by Parker’s Wide-field Imager for Solar Probe (WISPR) instrument.

When the image of the Earth was taken, Parker Solar Probe was about 27 million miles from Earth. The average distance between the Sun and Earth is 93 million miles.

Continue reading “NASA’s Parker Solar Probe snaps Earth pic as its speeds to the Sun” »

This discovery not only opened up an exciting new field of research, but has opened the door to many intriguing possibilities. One such possibility, according to a new study by a team of Russian scientists, is that gravitational waves could be used to transmit information. In much the same way as electromagnetic waves are used to communicate via antennas and satellites, the future of communications could be gravitationally-based.

The study, which recently appeared in the scientific journal Classical and Quantum Gravity, was led by Olga Babourova, a professor at the Moscow Pedagogical State University (MPSU), and included members from Moscow Automobile and Road Construction State Technical University (MADI) and the Peoples’ Friendship University of Russia (RUDN).

Continue reading “It Could be Possible to Transfer Data Through Gravitational Waves” »

Flu sufferers now have a new option for relieving symptoms. Xofluza (baloxavir marboxil), a single-dose, oral prescription drug, was approved by the US Food and Drug Administration on Wednesday. The antiviral is the first new flu treatment approved by the FDA in nearly 20 years, FDA Commissioner Dr. Scott Gottlieb said in a statement.

“With thousands of people getting the flu every year, and many people becoming seriously ill, having safe and effective treatment alternatives is critical,” said Gottlieb.

The pill is intended for patients who are 12 or older and who have had symptoms for no more than 48 hours. When patients with the flu, a respiratory illness, are treated within 48 hours of becoming sick, antiviral drugs can reduce symptoms and duration of illness, according to the FDA.